msmuthu.phe's picture
Dr. M. S. Muthu
Associate Professor
Department of Pharmaceutical Engineering and Technology, IIT(BHU)
msmuthu.phe@iitbhu.ac.in
9235195928
Area of Interest: 
Pharmaceutical Nanotechnology, Theranostics, Cancer Nanomedicine

E-mail: msmuthu.phe@itbhu.ac.in           
            muthubits@rediffmail.com

EDUCATION:

  • B Pharm.(2002): S.B.College of Pharmacy, Dr.M.G.R.Medical University, Tamil Nadu.

  • M Pharm.(2004): Faculty of Pharmacy, Birla Institute of Technology & Science, Pilani.

  • Ph. D.(2009): Department of Pharmaceutics, IIT (BHU), Varanasi.

  • Post-Doc. (2 Yrs): Faculty of Engineering, National University of Singapore, Singapore

  • Teaching: 11 years
  • Research: 14 years
  • Undergraduate:
        • Industrial Pharmacy
        • Physical Pharmaceutics
        • Clinical Pharmacy
        • Dispensing Pharmacy
        • Microbiology and Biotechnology
  • Postgraduate:
        • Nanopharmaceutics
        • Industrial Pharmacy
        • Drug Regulatory Affairs
        • Advanced Pharmaceutical Analysis
  • Ph. D.
        • Reseach Methodology
        • Advanced Chemical and Bioanalytical Technique 
  • Cancer Nanomedicine, Targeted Drug Delivery Systems
  • Theranostic Drug Delivery for Brain Cancer
  • Theranostic Drug Delivery for Tuberculosis
S.NO. Project title Scheme, Funding agency, and Duration Amount P.I. or Co.P.I. Status
1. Studies on micelles loaded with paliperidone palmitate UGC-XI Plan Scheme, No. 4121, 2011-2012 1 Lakh P.I. Completed
2. Transferrin receptor targeted Vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats SERB, DST, India
(FT/SR/LS-132/2011)
2012-2015
24.82 Lakh P.I. Completed
3. Polymeric nanoparticles as drug delivery systems for effective cancer therapy DST, India SR/BY/L-41/09, 2010-2011 17.43 Lakh P.I. Completed
4. Molecular biomaterials for brain-targeted nano drug delivery DBT-CREST Awards/26/MSM/2012-13, 2013-2014 23 Lakh P.I. Completed
5. TPGS-chitosan nanoparticles for cancer therapy: formulation, characterization, and in-vitro fluorescence study Institute Seed Money,
IIT-BHU
10 Lakh P.I. Completed
6. Targeted theranostic nanomedicine for brain cancer therapy R&D/BIRAC/SGAward/Phe/17-18/31 15 Lakh P.I. Ongoing
7. Chitosan-folate cross-linked TPGS nanomedicine for site-specific cancer therapy Institute Research Support,
IIT-BHU
15 Lakh P.I. Ongoing
  Total    107 Lakh    
 

Papers Published (National & International) : 69

  • International                                                      :  62 
  • National                                                              :  07
  • Cumulative impact factor                                 : 260
  • Average impact factor                                       : 4.6
  • h-index                                                                : 28                                         
  • RG Score                                                            : 35                                                            
  • Citations                                                             : 2300

 

  • Recent Publications:
                   Title Authors Journal Volume Page Year
    1. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials.
    Muthu, M.S., Kulkarni, S.A., Raju, A, and Feng, S.S. Biomaterials
     
    Impact Factor: 8.402
    33 3494-3501 2012
    1. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. 
    Muthu, M.S and Feng, S.S. Expert Opinion on Drug Delivery
     
    Impact Factor: 5.657
    10 (2) 151-155 2013
    1. Nanotheranostics – Application and further development of nanomedicine strategies for advanced theranostics.
    Muthu, M.S, Leong D.T, Mei L, and Feng, S.S. Theranostics
     
    Impact Factor: 8.712
    4 (6) 660-677 2014
    1. Nanotheranostics: advanced nanomedicine for integration of diagnosis and therapy. 
    Muthu, M.S., Mei, L, and Feng, S.S. Nanomedicine UK
     
    Impact Factor: 4.727
    9 (9) 1277-1280 2014
    1. Theranostic Vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters.
    Muthu, M.S., Kutty, R.V., Luo, Z., Xie, J and Feng, S.S. Biomaterials
     
    Impact Factor: 8.402
    39 3494-3501 2015
    1. Theranostic nanomedicine of gold nanoclusters: emerging platform for cancer diagnosis and therapy.
    Muthu, M.S., Agrawal, P, and Singh, S Nanomedicine UK
    Impact Factor: 4.727
    11 327-330 2016
    1. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulations and brain theranostics. 
    Sonali, Singh, R.P., Singh, N., Sharma, G., Vijayakumar, M.R., Koch, B., Sanjay, S., Singh, U., Dash, D., Pandey, B.L., Muthu, M.S. Drug Delivery
     
    Impact Factor: 4.843
    23 1261-1271 2016
    1. RGD-TPGS decorated theranostic liposomes for brain-targeted delivery.
    Sonali, Singh, R.P., Sharma, G., Kumari, L., Koch, B., Singh, S.,Bharti, S, Rajnikanth, P.S., Muthu, M.S. Colloids and Surfaces B: Biointerfaces
     
    Impact Factor: 3.887
    147 129-141. 2016
    1. Reality check for nanomaterials-mediated therapy with 3D biomimetic culture systems.
    Tay C.Y., Muthu M.S., Chia S.L., Nguyen K.T., Feng,S.S., Leong D.T. Advanced Functional Materials.
    Impact Factor: 12.12
    26 4046-4065 2016
    1. Nanotheranostics: Emerging strategies for early diagnosis and therapy of brain cancer.
    Sonali, Viswanadh M.K., Singh, R.P., Agrawal, P., Mehata, A.K., Pawde, D.M., Sonkar, R., Muthu. M.S. Nanotheranostics 2(1) 70-86 2018
 No. PUBLICATION DETAILS Impact Factor
2018
A. INTERNATIONAL
01 Singh, S. and Muthu, M.S. (2007): Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomedicine UK. 2 (2), 233-240. 4.717
02 Singh, S., Singh, J., Muthu, M.S., Balasubramaniam, J and Mishra, B. (2007): Gastroretentive drug delivery of metoclopramide Hcl: formulation and in- vitro evaluation. Current Drug Delivery. 4(4) 269-275. 1.645
03 Singh, S., Mahendra, K., Srivastava, A.K., Garg, A. and Muthu, M.S. (2007): Effect of permeation enhancers on the iontophoretic transport of timolol maleate through rat skin.  Acta Pharmaceutica Sciencia. 49 (3), 235-252. ---
04 Singh, S., Jain, S., Muthu, M.S and Tilak, R. (2008): Preparation and evaluation of buccal bioadhesive tablets containing clotrimazole. Current Drug Delivery. 5 (2), 133-141. 1.645
05 Singh, S., Jain, S., Muthu, M.S., Tiwari, S., Tilek, R. (2008): Preparation and    evaluation of buccal bioadhesive films containing clotrimazole. AAPS Pharm Sci Tech. USA 9(2), 660-667. 2.608
06 Muthu, M.S. and Singh, S. (2008): Studies on biodegradable polymeric nanoparticles of risperidone: in-vitro and in-vivo evaluation. Nanomedicine UK. 3(3) 305-319.  
4.717
07 Sunilson, A.J., Muthu, M.S., Mohan, M.S., Kumari, A.A.G., Thomas, J and Jeyaraj, P. (2008): Antidiabetic activity of MOMORDICA TUBEROSA (ROXB.) tuber extracts. Int J Pharmacol Biol Sci. 2(2), 41-45. ---
08 Muthu, M.S and Singh, S. (2009): Poly (D, L-Lactide) nanosuspension of risperidone for parentral delivery: formulation and in vitro evaluation. Current Drug Delivery. 5(1),62-68. 1.645
09 Muthu, M.S., Singh, S. (2009): Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine UK. 4(1), 105-118.  
4.717
10 Singh, S., Gajra, B., Muthu, M.S., Rawat, M., (2009): Enhanced transdermal delivery of ketoprofen from bioadhesive gel. Pakistan Journal of Pharmaceutical Sciences. 2(2), 193-198. 0.596
11 Muthu, M.S., Rawat, M.K., Mishra, A., Singh, S. (2009): PLGA nanoparticles formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine (NBM). 5(3), 323-333. (Listed in Science Direct Top 25 Hottest Articles – Rank is 15) 5.570
12
 
Muthu, M.S., Rajesh, C.V., Mishra, A., Singh, S. (2009): Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine UK. 4(6), 657-667.  
 4.717
13 Muthu, M.S. and Feng, S.S. (2009): Pharmaceutical stability aspects of nanomedicines.  Nanomedicine UK. 4 (8), 857-860.    4.717
14 Rawat M.K., Jain A., Mishra, A., Muthu M.S., Singh, S. (2010): Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Current Drug Delivery. 7 (1), 44-50. 1.645
15 Muthu, M.S. and Wilson, B. (2010): Multifunctional radionanomedicine: a novel platform for effective cancer imaging and therapy.  Nanomedicine UK. 5 (2), 169-171. 4.717
16 Singh, S., Soni, R., Rawat, M.K., Jain, A., Deshpande, S.B., Singh, S.K., and Muthu, M.S. (2010): In vitro and in vivo evaluation of buccal bioadhesive films containing salbutamol sulphate. Chem. Pharm. Bulletin. 58(3), 307-311. 1.405
17 Rawat, M.K., Jain, A., Mishra, A., Muthu, M.S and Singh, S. (2010): Effect of lipid matrix on characteristics of repaglinide loaded solid lipid nanoparticles for oral delivery. Therapeutic Delivery. 1(1), 63-73. 2.00
 Cite core
18 Muthu, M.S. and Feng, S.S. (2010): Nanopharmacology of liposomes developed for cancer therapy.  Nanomedicine UK. 5(7), 1017-1019.   4.717
19 Wilson, B., Samanta, MK., Muthu, M.S and Vinothapooshan, G. (2011): Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat alzheimer’s disease. Therapeutic Delivery. 2 (5), 599-609.    2.00
Cite Score
20 Muthu, M.S. and Feng, S.S. (2011): Targeted nanomedicine for the detection and treatment of circulating tumour cells.  Nanomedicine UK. 6 (4), 579-581.   4.717
21 Muthu, M.S., Kulkarni, S.A., Xiong, J and Feng, S.S. (2011): Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. International Journal of Pharmaceutics. 421 (2), 332-340.   4.213
22 Muthu, M.S., Kulkarni S.A., Yutao L and Feng, S.S. (2012): Development of docetaxel loaded Vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats.  Nanomedicine UK. 7 (3), 353-364.   4.717
23 Muthu, M.S. and Wilson, B. (2012): Challenges posed by the scale-up of nanomedicines.  Nanomedicine UK. 7 (3), 307-309.   4.717
24 Muthu, M.S., Kulkarni, S.A., Raju, A and Feng, S.S. (2012): Theranostic liposomes of TPGS coating for targeted co delivery of docetaxel and quantum dots. Biomaterials. 33, 3494-3501.   10.273
25
 
Muthu, M.S., Pandey B.L., Sahu, A.K. and Rajesh, C.V. (2012): Emerging patents for cancer-targeted nanomedicines. Pharmaceutical Patent Analyst. 1(2), 113-115. PubMed Indexed
26 Muthu, M.S (2012): Focus on the development of computer-aided nanomedicine design. Nanomedicine UK. 7(10), 1471-1473.   4.717
27 Lanjhiyana S.K., Bajpayee P., Kesavan K., Lanjhiyana S and Muthu, M.S. (2013): Chitosan-sodium alginate blended polyelectrolyte complexes as potential multiparticulate carrier system: colon targeted delivery and gamma scintigraphic imaging.  Expert Opinion on Drug Delivery. 10 (1), 5 -15.   5.400
28 Sahu, AK., Gautam, M.K., Deshmukh, P.T., Kushwah, L.S., Silawat, N., Akbar, Z and Muthu, M.S. (2013): Effect of embelin on lithium-induced nephrogenic diabetes insipidus in albino rats. Asian Pacific Journal of Tropical Disease. S729-S733. Scopus Indexed
29 Muthu, M.S and Feng, S.S. (2013): Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.  Expert Opinion on Drug Delivery. 10 (2), 151-155.   5.400
 
30
Vijayakumar M.R., Muthu, M.S. and Singh S (2013): Co-polymers of poly (lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Expert Opinion on Drug Delivery. 10 (4), 529-543.   5.400
31 Raju, A., Muthu, M.S. and Feng, S.S. (2013): Trastuzumab-conjugated Vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Expert Opinion on Drug Delivery. 10 (6), 747-760.    5.400
32 Muthu, M.S., Abdulla, A. and Pandey B.L. (2013): Major toxicities of carbon nanotubes induced by reactive oxygen species: should we worry about the effects on the lungs, liver and normal cells? Nanomedicine UK. 8 (6), 863-866.   4.717
33 Kesavan, K., Pandit, JK., Kant S and Muthu, M.S (2013): Positively charged microemulsions of dexamethasone: comparative effects of two co-surfactants on ocular drug delivery and bioavailability. Therapeutic Delivery. 4 (11), 1385-1395.     2.00 Cite Score
34 Muthu, M.S, Leong D.T, Mei L and Feng, S.S. (2014): Nanotheranostics – Application and further development of nanomedicine strategies for advanced theranostics. Theranostics. 4 (6), 660-677.   8.063
35 Muthu, M.S., Mei, L and Feng, S.S. (2014): Nanotheranostics: advanced nanomedicine for integration of diagnosis and therapy.  Nanomedicine UK. 9 (9), 1277-1280.   4.717
36 Muthu, M.S., Agrawal, P and Singh, R.P. (2014): Antipsychotic nanomedicine: a successful platform for clinical use.  Nanomedicine UK. 9 (14), 2401-2404.   4.717
37 Muthu, M.S., Kutty, R.V., Luo, Z., Xie, J and Feng, S.S. (2015): Theranostic Vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials. 39, 3494-3501.   10.273
38 Kutty, R.V., Chia, S.L., Setyawati, M.I., Muthu, M.S., Feng, S.S., Leong, D.T. (2015): In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials. 63, 58-69.   10.273
39 Kumar, D., Muthu, M.S., Pandey, B.L. (2015): Pharmacovigilance Programme in India: current status and its Indian perspectives. Research and Reviews: Journal of Pharmacology and Toxicological Studies. 3(3), 34-36.      ---
40 Muthu, M.S., Sahu A.K., Sonali., Abdulla, A., Kaklotar, D., Rajesh, C.V., Sanjay, S and Pandey B.L. (2016): Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug Delivery. 23, 230-37.   3.095
41 Muthu, M.S., Agrawal, P and Singh, S (2016): Theranostic nanomedicine of gold nanoclusters: emerging platform for cancer diagnosis and therapy. Nanomedicine UK. 11:327-30.   4.717
42 Singh, R.P., Sharma, G., Sonali, Agrawal, P., Pandey, B.L., Koch, B., Muthu, M.S. (2016): Transferrin receptor-targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery. International Journal of Biomacromolecules. 83:335-44.   4.784
43 Singh, R.P., Sharma, G., Sonali., Singh, S., Kumar, M., Pandey, B.L., Koch, B., Muthu M.S. (2016): Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment. Colloids and Surfaces B: Biointerfaces. 141:429-42.   3.973
44 Sonali, Singh, R.P., Singh, N., Sharma, G., Vijayakumar, M.R., Koch, B., Sanjay, S., Singh, U., Dash, D., Pandey, B.L., Muthu, M.S. (2016): Transferrin liposomes of docetaxel for brain targeted cancer applications: formulations and brain theranostics.  Drug Delivery. 23, 1261-71.   3.829
45 Sonali, Agrawal, P., Singh R.P., Rajesh, C.V., Sanjay, S., Vijayakumar M.R., Pandey B.L., Muthu, M.S. (2016): Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Delivery. 23, 1788-1798.   3.829
46 Tay C.Y., Muthu M.S., Chia S.L., Nguyen K.T., Feng S.S., Leong D.T. (2016): Reality check for nanomaterials-mediated therapy with 3D biomimetic culture systems. Advanced Functional Materials. 26, 4046-4065.   15.621
47 Kaklotar, D., Agrawal, P., Abdulla, A., Singh, R.P., Sonali., Mehata, A.K., Singh, S., Mishra, B., Trigunayat, A., Pandey, B.L., Muthu M.S. (2016): Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycaemic control in diabetes. Nanomedicine 11(11), 1465-1486.   4.717
48 Prakash, S., Muthu, M.S., and Singh, S (2016): Adiponectin enhancers: treatment options for obesity and diabetes. Research and Reviews: Journal of Pharmacology and Toxicological Studies. 4(1), 24-26.     ---
49 Singh, R.P., Sharma, G., Sonali., Singh, S., Patne, S.C.U., Pandey, B.L., Koch, B., Muthu M.S. (2016): Effects of transferrin conjugated multi-walled carbon nanotubes in lung cancer delivery. Material Science and Engineering: C. C 67, 313-325.   4.959
  50 Vijayakumar, M.R., Vajanthri, K.Y., Balavigneshwaran, C.K., Mahto, S.K., Mishra, N., Muthu M.S. and Singh S (2016): Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes. Colloids and Surfaces B: Biointerfaces. 145, 479-491.   3.973
  51 Vijayakumar,M.R., Kosuru,R., Singh,S.K., Prasad,C.B., Narayan,G., Muthu,M.S. (2016): Resveratrol loaded PLGA: d-α-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy. RSC Advances. 6, 74254-74268.   3.049
  52 Sonali, Singh, R.P., Sharma, G., Kumari, L., Koch, B., Singh, S.,Bharti, S, Rajnikanth, P.S., Pandey, B.L., Muthu, M.S. (2016): RGD-TPGS decorated theranostic liposomes for brain targeted delivery. Colloids and Surfaces B: Biointerfaces. 145, 479-491.   3.973
  53 Mishra, B., Upadhyay, M., Reddy Adena S.K., Vasant, B.G., Muthu M.S. (2017): Hydrogels: an introduction to a controlled drug delivery device, synthesis and application in drug delivery and tissue engineering. Austin Journal of Biomedical Engineering. 4 (1), 1037.     ---
  54 Agrawal, P., Sonali, Singh, R.P., Sharma, G., Koch, B., Singh, S., Mehata, A.K., Rajesh, C.V., Pandey, B.L., Muthu, M.S. (2017): Bioadhesive micelles of D-α-tocopheryl polyethylene glycol succinate 1000: synergism of chitosan and transferrin in targeted drug delivery. Colloids and Surfaces B: Biointerfaces. 152, 277-288.   3.973
  55 Agrawal, P., Singh, R.P., Sonali, Kumari, L., Mehata, A.K., Sharma, G., Singh, S., Rajesh, C.V., Koch, B., Pandey, B.L., Muthu, M.S. (2017): TPGS-chitosan crosslinked targeted nanoparticles for effective brain cancer therapy. Material Science and Engineering: C.  74, 167-176.   4.959
  56 Muthu M.S., Mehata, A.K., Viswanadh, M.K. (2017): Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy. Nanomedicine 12(6), 577-580.  4.717
  57 Singh R.P., Sharma G., Sonali., Muthu M.S. (2017): Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery. Mater Sci Eng C Mater Biol Appl. 77, 446-458.  4.959
  58 Sonali, Viswanadh M.K., Singh, R.P., Agrawal, P., Mehata, A.K., Pawde, D.M., Narendra., Sonkar, R., Muthu. M.S. (2018): Nanotheranostics: Emerging strategies for early diagnosis and therapy of brain cancer. Nanotheranostics. 2(1), 70-86.      --
59 Viswanadh, M.K., Muthu, M.S. (2018): Targeted bioadhesive nanomedicine: An
effective approach for synergistic drug delivery to cancers. Nanomedicine (Lond.) 13(12), 1401–1403.
 4.717
60 Muthu, M.S., and Sonali (2018): Stem cell therapy and nanomedicine for Alzheimier’s disease. Research and Reviews: Journal of Pharmacology and Toxicological Studies. 6(2), 14-17.      --
61 Mehata A.K, Bharti S, Singh P, Viswanadh M.K, Kumari L, Agrawal P, Singh S, Koch B, Muthu. M.S. (2019): Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy. Colloids and Surfaces B: Biointerfaces. 173, 366-377.  3.973
62

Patel KK, Surekha DB, Tripathi M, Anjum MM, Muthu MS, Tilak R, Agrawal AK, Singh S. Anti-biofilm potential of silver sulfadiazine loaded nanoparticle formulations: a study on the role of DNase-I in microbial biofilm and wound healing activity. Mol. Pharm. 2019. doi: 10.1021/acs.molpharmaceut.9b00527.

4.396
  B. NATIONAL  
 63      Singh, S., Singh, J., Muthu, M.S and Mishra, B (2006): Prolonged gastric retention: floating microspheres for oral controlled drug delivery. The Indian Pharmacist. 5 (53), 61-68. ---
64 Pandit, J.K., Singh, S and Muthu, M.S. (2006): Controlled release formulations in neurology practice: A review. Annals of Indian Academy of Neurology. 9 (4), 207-216.   0.898
65 Muthu, M.S (2009): Nanoparticles based on PLGA and its co-polymer: An overview. Asian Journal of Pharmaceutics. 3(4), 266-273. Scopus Indexed
66 Singh, R.P., Sonali, Mehata, A.K., Agrawal, P., Singh, S., Muthu, M.S. (2016): Carbon nanotubes: super-fabric tiny materials as lung cancer theranostics. The Pharmstudent. 27, 55-78. ---
 
67 Mehata, A.K., Dubey, T., Bhanukiran, K., Dehari, D., Priya, V., Muthu, M.S. (2017): Receptor targeted nanomedicine as emerging platform for brain cancer therapy: an review article. World Journal of Pharmaceutical Research. 6, 487-497. ---
 
68 Sonali, Singh, R.P., Viswanadh, M.K., Singh, S., Muthu, M.S. (2017): Mesoporous Silica Nanoparticles for Brain Cancer Theranostics. The Pharmstudent. 28, 36–44. ---
69 Sah, A.K., Muthu, M.S., Singh, S: (2017): Poly (D, L, Lactide-co-glycolide) (PLGA): A novel biodegradable polymer for ocular therapeutics. The Pharmstudent. 28, 59-65.  
 

Research Guidance

Ph.D.               : Completed: 3, Ongoing: 4
Ph. D. Scholars under supervision:
1. Matte Kasi Viswanadh
2. Vikas Sharma
3. Vishnu Priya
4. Abhishesh Kr Mehata

PG                                 : Completed: 5, Ongoing: 5
PG Students under supervision:
1. Abhishek Jha
2. Ankita S Burande
3. Jitendra Patel
4. Shaik Azad
5. Nishi Agrawal

Exploratory Project     : 10
UG                                 : 10
External Fellowships   : RGNF (02-Completed)

Awards/Honors:

  • Class Topper in B.Pharm. S.B. College of Pharmacy, Sivakasi, Tamilnadu.
  • M.Pharm. GATE Scholarship University Grant Commission, New Delhi.
  • Stipend Cadila Pharmaceuticals Limited, Ahmedabad, Gujarat.
  • Senior Research Fellowship Banaras Hindu University, Varanasi- University Grant Commission, New Delhi, India.
  • BOYSCAST FELLOWSHIP (2009-10) Department of Science and Technology (DST), India.
  • Academic Excellence Award (2012) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • DBT-CREST AWARD (2012-13) Department of Biotechnology (DBT), India.
  • IMS-Research Publication Award (2013) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • IMS-Research Publication Award (2014) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • VICE-CHANCELLOR’S MEDICAL RESEARCH AWARD (2014) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • International Faculty Award (VIFA-2016), Venus International Foundation, Chennai, India.
  • Best Young Scientist Award (2016) Pearl Foundation, Madurai, India.
  • BIRAC-DBT- Gandhian Young Technological Innovation (GYTI) Award - 2017.

Recognitions:

  • Cancer Nanotechnology, Nano Drug Delivery Techniques - Workshop, Department of Pharmaceutics, PSG College of Pharmacy, Coimbatore (TN), 27 April, 2012.
  • Nano drug formulations: better options for anti-psychotic and anti-cancer therapy, NASI-Young Scientist Platinum Jubilee Award, National Academy of Sciences, India, Allahabad (UP), 19 July, 2012.
  • Anti-psychotic Nanomedicine and Cancer Theranostics, INSA-Young Scientist Award, Indian National Science Academy, India, New Delhi, April, 2013.
  • Targeted theranostics nanomedicine: formulation, characterization and cancer application. Biomaterials in Medicinal Chemistry National Conference at Department of Natural Chemistry at Madurai Kamaraj University, Madurai, India during 14 April 2017.
  • 2nd Prize for poster presentation, M.Tech. level, Institute Day – 2017, Indian Institute of Technology (BHU), Varanasi -221005.
  • 1 st Prize for poster presentation, NIPiCON – 2018, International conference on “Innovation in Pharmaceutical Research by Interdisciplinary Approach’’ in Nirma Institute of Pharmacy, Ahmedabad, Gujarat.
  • Nanotheranostics: micelles for early diagnosis and therapy of cancer. Nanopharmaceutics and Advanced Drug Delivery held on 17th August 2018 in Dublin, Ireland.

Reviewer for Journals:

  • Biomaterials (Publisher – Elsevier, U.S.A)
  • Nanomedicine: Nanotechnology Biology and Medicine (Publisher – Elsevier, U.S.A)
  • Journal of Controlled Release (Publisher – Elsevier, U.S.A)
  • Nanoscience and Nanotechnology Letters (Publisher – American Scientific Publishers)
  • Nanomedicine (Publisher – Future Medicine, U.K)
  • Molecular Pharmaceutics (Publisher – American Chemical Society)
  • International Journal of Pharmaceutics (Publisher – Elsevier, U.S.A)
  • Expert opinion on drug delivery (Publisher – Informa healthcare, USA)
  • Journal of Pharmacy and Pharmacology (Publisher – Wiley, U.K)
  • Drug Delivery (Publisher – Informa healthcare, USA)
  • Therapeutic Delivery (Publisher – Future Science, U.K) and more….

Editor/Editorial board member for Journals:

  • Editor-in-Chief: Research and Reviews: Pharmacology and Toxicology Studies
  • ISRN Biomedical imaging (Publisher – Hindawi, U.S.A)
  • ISRN Pharmaceutics (Publisher – Hindawi, U.S.A)
  • ISRN Biomaterials (Publisher – Hindawi, U.S.A)
  • World Journal of Methodology
  • BioMed International (Pharmaceutics – Lead Guest Editor) (Publisher – Hindawi, U.S.A)
  • Life Member:
    • American Nano Society  (U.S.A)
    • British Society for Nanomedicine (U.K.)

  • Registration:
    •  Pharmacy Council of India (PCI)